Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-1292-2019

Drug recall · May 22, 2019

Titanium 4000 recall

Why: Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020

Lots / codes

Expiration 12/29/2020

Quantity
unknown
Company
D.B.P. Distribution, Chatsworth, CA
Distribution
Nationwide.
Initiated
April 23, 2019 · Voluntary: Firm initiated
Classified
May 22, 2019
Reported
May 22, 2019
Ended
March 7, 2023
How notified
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.